We present a case of a severe reaction to sulindac. A 30-year-old woman with quiescent systemic lupus erythematosus received sulindac for nonspecific migrating chest pain. An initial course of therapy produced an unrecognized sensitization to the drug with a febrile illness and rash. Readministration of the drug caused an anaphylactoid reaction as well as evidence of cardiovascular, hepatic, pulmonary, and hematologic dysfunction. The patient's illness had evidence of types I, II, and III hypersensitivity reactions.
(Arch Intern Med. 1991;151:387-388)
Hyson CP, Kazakoff MA. A Severe Multisystem Reaction to Sulindac. Arch Intern Med. 1991;151(2):387–388. doi:10.1001/archinte.1991.00400020127027
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.